Outsourcing Vendor Red Flag #2: Layers of Oversight And Process Are Impeding My Program
Depth of management typically is less about ensuring your trial progresses smoothly and more about...Continue reading→
Outsourcing Vendor Red Flag #3: A Bid Is Inaccurate Or Suspiciously Low
Adept CRO communication doesn’t just indicate the vendor’s ability to deliver a thoughtful bid; it...Continue reading→
Strategies for a More Secure Outsourcing Bottom Line
The article discusses strategies for securing a more stable and cost-effective outsourcing process in clinical...Continue reading→
Leveraging Clinical Trial Data In Real Time To Effect Change And Mitigate Risk
The article discusses the untapped potential of real-time clinical trial data analytics to improve trial...Continue reading→
Why Collaborative Protocol Design Is Vital To Autologous Cell Therapy Clinical Trials
Collaborative protocol design is essential in the development of autologous cell therapy clinical trials, as...Continue reading→
Remote Clinical Trial Monitoring: CRA Success In An Era Of Autonomy
The COVID-19 pandemic has accelerated the adoption of remote work in clinical trials, particularly among...Continue reading→
Why Site And Partner Communications Are Critical To Autologous Cell Therapy Clinical Trials
Effective communication between clinical trial sites and partners is crucial for the success of autologous...Continue reading→
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials
Efficient time management, streamlined logistics, and standardized manufacturing processes are critical for the success of...Continue reading→
Clinical Research Considerations For Rare Disease Patients: Part 1 — Reinvigorate Patient Centricity
The article emphasizes the need for a shift towards patient-centric approaches in clinical research, especially...Continue reading→
Clinical Research Considerations For Rare Disease Patients: Part 2 — The Impact Of Physician And Site Support
Physician and site support are critical for the success of rare disease clinical trials, where...Continue reading→
The Write Side of AI: Helping Hands, Not Replacement Plans
The article explores the role of AI in medical writing, emphasizing that while AI offers...Continue reading→
Slow the Burn: How to Mitigate Financial Risk Before Selecting an Outsourcing Vendor
This webinar explores how clinical trial sponsors can proactively mitigate financial risks by carefully examining...Continue reading→
Philadelphia Business Journal’s 2025 Best Places to Work
FOR IMMEDIATE RELEASE inSeption Group Named One of Philadelphia Business Journal’s 2025 Best Places to...Continue reading→
inSeption Group Partners with Pennsylvania Biotechnology Center
FOR IMMEDIATE RELEASE inSeption Group Partners with Pennsylvania Biotechnology Center to Support Early-Stage Biotech Companies...Continue reading→
Recovering A Clinical Trial That Has Been Derailed
When your asset is on the line, your partner of choice matters more than ever....Continue reading→
Dawn Niccum Named CPR Chair-Elect, 2024
inSeption Group is thrilled to announce that Dawn Niccum has been designated as Chair-Elect of...Continue reading→
Entrepreneur of the Year
inSeption Group Co-Founders and Managing Partners Joe Arcangelo and Brian Sulpizio Named as EY Entrepreneurs...Continue reading→
Philadelphia Business Journal’s Fast 50 Growing Companies 2024
[Lansdale, PA] – [August 13th, 2024] – inSeption Group, a leading clinical outsourcing company, is proud...Continue reading→
Lori Buckenmyer
Meet our Executive Director, Clinical Operations and Project Management
Dawn Niccum
Meet our Executive Vice President, Quality Assurance
How To Build Effective Clinical Trial Oversight And Leadership
Sponsor-led oversight is critical in clinical trials, even when strategic input and operational tasks are...Continue reading→